Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial

NCT03871491 is registered in ClinicalTrials.gov with NICHD Global Network for Women's and Children's Health as lead sponsor.

NCT NCT03871491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial
Lead sponsor
NICHD Global Network for Women's and Children's Health
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2020
Completion date
September 30, 2022
Enrollment
58,747 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

maternal death, maternal infections affecting fetus or newborn, maternal sepsis during labor, neonatal death, neonatal sepsis, postpartum sepsis